Abiraterone acts as a selective and irreversible inhibitor of CYP17A1, a critical enzyme in the steroidogenesis pathway responsible for androgen production in the testes, adrenal glands, and tumor microenvironment [28]. This evidence concerns the gene CYP17A1 and neoplasm.